| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9310822 | Kidney International | 2005 | 5 Pages |
Abstract
The podocyte phenotypic changes assessed in a model of obesity and type II diabetes mellitus were corrected by an angiotensin-converting enzyme (ACE) inhibitor. These results could be associated with an improvement in the slit diaphragm, and therefore, in the maintenance of the filtration barrier. Diltiazem did not achieve similar results.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sandra Blanco, Josep Bonet, Dolores López, Irma Casas, Ramón Romero,